All In Biotech

Drug Trial Radar · NCT01347710

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

A Phase 3, Open Label, Multicenter Study for the Assessment of Myocardial Perfusion Using Positron Emission Tomography (PET) Imaging of Flurpiridaz F18 Injection in Patients With Suspected or Known Coronary Artery Disease (CAD)

Last checked: Nov 20, 2026Latest source record: Nov 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

795

Actual

Start

Jun 2011

Primary completion

Jul 2013

Study completion Sep 2013

Sponsor

Lead sponsor
Lantheus Medical ImagingIndustry
Sponsor type
Industry
First posted
May 4, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to assess the diagnostic efficacy (specificity and sensitivity) of flurpiridaz F18 injection PET myocardial perfusion imaging (MPI) compared to single photon emission computed tomography (SPECT) MPI in the detection of significant coronary artery disease (CAD) as defined by invasive coronary angiography (ICA) or a documented history of Myocardial Infarction (MI).

Conditions

  • Coronary Artery Disease

Interventions

  • Flurpiridaz F18Drug

    Injection of Flurpiridaz F18 for the purposes of PET myocardial profusion imaging (MPI) analysis

  • 99mTechnicium (sestamibi or tetrofosmin)Drug

    Injection of 99mTc sestamibi or tetrofosmin for the purposes of SPECT MPI analysis

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diagnostic Efficacy of Flurpiridaz F 18 PET Myocardial Perfusion Imaging (MPI) Sensitivity Versus SPECT Myocardial Perfusion Imaging SensitivityTime frame: 60 days
  2. Diagnostic Efficacy of Flurpiridaz PET MPI Specificity Versus SPECT MPI SpecificityTime frame: 60 days

Locations

81 sites in 4 countries. Site status is shown where the registry gives one.

  • Cardiology Associates of Mobile, Inc.

    Mobile, Alabama

  • Scottsdale Medical Imaging, Ltd.

    Scottsdale, Arizona

  • West Side Medical Associates of Los Angeles

    Beverly Hills, California

  • USC PET Imaging Science Center

    Los Angeles, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • VA West Los Angeles Medical Center

    Los Angeles, California

  • UCLA

    Los Angeles, California

  • Veterans Affairs Palo Alto Health Care System

    Palo Alto, California

  • Cardiovascular Consultants Medical Group

    Pleasant Hill, California

  • Northern California PET Imaging Center-Palo Alto

    Sacramento, California

  • VA San Diego Healthcare System

    San Diego, California

  • UCSF Medical Center

    San Francisco, California

  • Yale University

    New Haven, Connecticut

  • Alfieri Cardiology

    Newark, Delaware

  • Christiana Care Health System

    Newark, Delaware

  • Elite Research and Clinical Trials

    Aventura, Florida

  • Independent Imaging, LLC

    Boynton Beach, Florida

  • Coastal Cardiology Consultants dba The Heart & Vascular Institute of Florida

    Clearwater, Florida

  • Florida Heart Associates

    Fort Myers, Florida

  • St. Luke's Cardiology Associates

    Jacksonville, Florida

  • The Cardiovascular Center, PA

    Lake Mary, Florida

  • Florida Hospital/Cardiovascular Institute (Florida Heart Group)

    Orlando, Florida

  • South Florida Research Solutions

    Pembroke Pines, Florida

  • Memorial Hospital of Tampa

    Tampa, Florida

  • Georgia Health Sciences Univ/Med College of GA

    Augusta, Georgia

  • South Coast Imaging Center

    Savannah, Georgia

  • Gateway Cardiology, PC

    Jerseyville, Illinois

  • Norton Cardiovascular Associates

    Louisville, Kentucky

  • Biomedical Research Foundation of Northwest Louisiana

    Shreveport, Louisiana

  • Maine Research Associates

    Auburn, Maine

  • Johns Hopkins University

    Baltimore, Maryland

  • Mass General Hospital (MGH)

    Boston, Massachusetts

  • Boston University Medical Center

    Boston, Massachusetts

  • University of Michigan Health System

    Ann Arbor, Michigan

  • Wayne State University - Harper University Hospital

    Detroit, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • St. Mary's Healthcare (Trinity Health)

    Grand Rapids, Michigan

  • McLaren Macomb

    Mount Clemens, Michigan

  • William Beaumont Hospital

    Royal Oak, Michigan

  • Hattiesburg Clinic

    Hattiesburg, Mississippi

Showing 40 of 81 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.